Modern approaches to obesity therapy: efficiency problems
- Авторлар: Kurnikova I.A.1, Gulova S.G1, Buturlina S.A1, Mokhammed I.1
-
Мекемелер:
- Peoples' Friendship University of Russia
- Шығарылым: Том 29, № 4 (2022)
- Беттер: 76-80
- Бөлім: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/320975
- DOI: https://doi.org/10.18565/pharmateca.2022.4.76-80
- ID: 320975
Дәйексөз келтіру
Аннотация
Негізгі сөздер
Толық мәтін
Авторлар туралы
Irina Kurnikova
Peoples' Friendship University of Russia
Email: curnikova@yandex.ru
Dr. Sci. (Med.), Professor, Professor at the Department of Hospital Therapy with Courses of Endocrinology, Hematology and Clinical Laboratory Diagnostics, Medical Institute, Curator of the Course of Endocrinology
Sh. Gulova
Peoples' Friendship University of Russia
S. Buturlina
Peoples' Friendship University of Russia
I. Mokhammed
Peoples' Friendship University of Russia
Әдебиет тізімі
- Arroyo-Johnson C., Mincey K.D. Obesity Epidemiology Worldwide. Gastroenterol Clin North Am. 2016;45(4):571-79. Doi: 10.1016/j. gtc.2016.07.012.
- Bastard J., Maachi M., Lagathu C., et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw. 2006;17(1):4-12.
- Клиническая рекомендация по ожирению 2020. URL: https://rae-org.ru/system/files/ documents/pdf/ozhirenie_vzroslye.pdf
- Farooq M.A., Parkinson K.N., Adamson A.J., et al. Timing of the U/cIp/ in physical activity in childhood andoUol1oc1PC1: Gateshead Millennium Cohort Study. Br J. Sports Med. 2018;52:1002-6. doi: 10.1136/bjoporto-2016-096933.
- Lenz M., Richter T., Muhlhauser I. The morbidity and mortality associated with overweight and obesity in adulthood: a systematic review. Dtsch Arztebl Int. 2009;106:641-48. Doi: 10.3238/ arztebl.2009.0641
- Heymofield S.B., Waddep T.A. Mechanisms, Pathophysiology, and Management of Obesity. N. Engl J. Med. 2017;376(3):254-66. doi: 10.1056/NEJMra1514009.
- Yeo G., Heisler L. Unraveling the brain regulation of appetite: lessons from genetics. Nat Neurosci. 2012;15(10):1343-49. doi: 10.1038/pp.3211.
- Zhi C., Huang J., Wang J., et al. Connection between gut microbiome and the U1V1lopm1Pt of obesity. Eur J. Clin Microbiol Infect Dis. 2019;Jul 31. doi: 10.1007/s10096-019-03623-x.
- Fromentin C., Tomé D., Nau F., et al. Dietary proteins contribute little to glucose production, even under optimal gluconeogenic conditions in healthy humans. Diabetes. 2013;62(5):1435-42. doi: 10.2337/db12-1208.
- Veldhuis J.D., Sharma A., Roelfsema F., et al. Age-dependent and gender-dependent regulation of hypothalamic-adrenocorticotropic-adrenal axis Endocrinol Metab Clin North Am. 2013;42(2):201-25. Doi: 10.1016/j. ecl.2013.02.002
- Бобров А.Е., Гегель Н.А., Гурова О.Ю. Особенности поведения больных с избыточной массой тела и ожирением. Альманах клинической медицины. 2014;32:3-7.
- Зайцев В.П., Зайцев В.П. Психологическая реабилитация больных. Медицинская реабилитация. Под ред. В.М. Боголюбова. М.: БИНОМ, 2010. Т. 1. С. 325-47.
- Дадаева В.А., Еганян РА., Королев А.И. и др. Типы нарушений пищевого поведения. Профилактическая медицина. 2021;24(4): 113-19. Doi: 10.17116/ profm1U202124041113.
- Geliebter A., Christopher N., Ochner C.N., et al. Obesity-related hormones and metabolic risk factors: a randomized trial of diet plus either strength or aerobic training versus diet alone in overweight participants. J Diabetes Obes. 2015;1:1-7.
- Stephens S.K., Cobiac L.J., Leppert Veermap. J. Improving diet and physical activity to reduce population prevalence of overweight and obesity: An overview of current evidence. Preventive Medicine. 2014;62:167-78. Doi: 10.1016/j. ypm1d.2014.02.008.
- Heymsfield S.B., Waddep T.A. Mechanisms, Pathophysiology, and Management of Obesity. N. Engl J. Med. 2017;376(3):254-66. doi: 10.1056/NEJMm1514009.
- Guh D., Zhang W., Bansback N., et al. The incidence of co-morbidities related to obesity and overweight: a systematic review and metaanalysis. BMC Public Health. 2009;9:88. doi: 10.1186/1471-2458-9-88.
- Jensen M.D., Ryan D.H., Apovian C.M., et al.; American College of Cardiology/American Heart Association Task Force on Practice Guidelines, Obesity Society. 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults: a report of the American College of Cardiology. American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014;129(suppl 2):S102-S138. doi: 10.1161/01.cir.0000437739.71477.ee
- Garvey WT, Mechanick J.I., Brett E.M., et al.; Reviewers of the AACE/ACE Obesity Clinical Practice Guidelines. American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocr Pract. 2016;22(Suppl 3):1-203. doi: 10.4158/EP161365.GL.
- Wirth A. Reduction of body weight and comorbidities by rollstart: The XXL primary Health Care Trial. Diabetes Obes. Metabol. 2005;7:2122. doi: 10.1111/j.1463-1326.2004.00428.x.
- Toplak H., Ziegler O., Keller U., Hamann A., et al. X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet. Early response to treatment predicts weight maintenance. Diabetes Obes Metab. 2005;7:699-708. doi: 10.1111/j.1463-1326.2005.00483.x.
- Torgerson J.S., Hauptman J., Boldrin M.N., et al. XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care. 2004;27:155-61. doi: 10.2337/ diacare.27.1.155.
- Zheng J., Greenway F.L. Caenorhabditis elegans as a model for obesity research. Int J. Obes (Lond). 2012;36(2):186-94. doi: 10.1038/ ijo.2011.93.
- Neary M.T., Batterham R.L. Gut hormones: implications for the treatment of obesity Pharmacol Ther. 2009;124(1):44-56. doi: 10.1016/j.pharmthera.2009.06.005.
- Culbert K., Racine S., Klump K. Research Review: What we have learned about the causes of eating disorders - a synthesis of sociocultural, psychological, and biological research. J. Child Psychol Psychiatry. 2015;56(11):114164. doi: 10.1111/jcpp.12441.
- Peeters A.V., Beckers S., Verrijken A. Common variants in the gene for the serotonin receptor 6 (HTR6) do not contribute to obesity. J. Genet. 2010;89(4):469-72. doi: 10.1007/s12041-010-0066-2.
- Власова И.И., Аметов А.С. Влияние терапии Сибутрамином (Меридиа) на композиционный состав тела, уровни пептида YY3-36 и серотонина у пациентов с экзо- генно-конституциональным ожирением. Терапевтический архив. 2010;82(8):44-7.
- Caterson I.D., Finer N., Coutinho W., et al. Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial. Diabetes Obes Metab. 2012;14(6): 523-30. doi: 10.1111/j.1463-1326. 2011.01554.x.
- Аметов А.С. Эффективное лечение ожирения-путь борьбы с эпидемией Diabetus mellipidus. Медицинский совет. 2013;2:78-83. doi: 10.21518/2079-701X-2013-2-2-78-83.
- Дедов И.И., Мельниченко ГА., Романцова Т.И. Стратегия управления ожирением: итоги Всероссийской наблюдательной программы «ПримаВера». Ожирение и метаболизм. 2016;1:36-44.
- Dedov I.I., еt al. Body Weight Reduction Associated with the Sibutramine Treatment: Overall Results of the PRIMAVERA Primary Health Care Trial. Obes Facts. 2018;11:335-43. doi: 10.1159/000488880.
- Campbell J.E., Drucker D.J. Pharmacology, physiology, and mechanisms of incretin hormone action. Cell Metab. 2013;17(6):819-37. doi: 10.1016/j.cmet.2013.04.008.